Results 151 to 160 of about 3,859 (214)

The arginine metabolism battlefield: how metabolite exchange in the tumor microenvironment shapes an immunosuppressive ecosystem. [PDF]

Cancer Biol Med
Zhu Y, Li H, Hu H, Hu H, Luo ML.
europepmc   +1 more source

Iwilfin (eflornithine) approved by the FDA as the first and only oral maintenance therapy for high-risk neuroblastoma in adult and pediatric patients: Narrative review. [PDF]

Medicine (Baltimore)
Shakeel A, Baloch A, Kumari V, Kazmi SKZ, Aftab K, Abid S, Syed A, Syed A, Yousuf J, Hasanain M, Anjum MU, Anjum MU, Mahmmoud Fadelallah Eljack M.   +12 more
europepmc   +1 more source

Polyamine metabolism and anti-tumor immunity. [PDF]

Front Immunol
Wu JY, Zeng Y, You YY, Chen QY.
europepmc   +1 more source

T_H17-Associated Polyamine Metabolism-Guided Nanozyme Promotes Alveolar Bone Repair in Periodontitis. [PDF]

Adv Sci (Weinh)
Zhu C, Li T, Jin Y, Li Y, Liu Q, Fang R, Qu L, Tang X, Li R, Zhao X, Hao J, Fang B, Xia L.   +12 more
europepmc   +1 more source

Multiomics analysis of polyamine metabolism in colorectal cancer, highlighting the key role of extracellular putrescine in impairing CXCR6⁺CD8⁺ T cell anti-tumor activity. [PDF]

PeerJ
Tan Z, Zhang Y, Pei Jia C, Lian H, Wang B.   +4 more
europepmc   +1 more source

Podocyte Metabolic Reprogramming and Targeted Therapy. [PDF]

J Am Soc Nephrol
Hu H, Liang W, Ding G.
europepmc   +1 more source

Eflornithine for treatment of high-risk neuroblastoma. [PDF]

Trends Pharmacol Sci
Jiang J, Yu Y.
europepmc   +1 more source

The remarkable legacy of the K6/ODC mouse: mechanisms of polyamine-promoted tumorigenesis revealed. [PDF]

Amino Acids
Gilmour SK.
europepmc   +1 more source

Opposite effects of spermidine and GC7 in cell culture are dictated by distinct molecular targets. [PDF]

Biochem J
Tahara T, Bordone R, Campese AF, Cantale Aeo NM, Astolfi R, Coni S, Ragno R, Canettieri G, Agostinelli E.   +8 more
europepmc   +1 more source

QW-5-70 Targets the Colchicine Site and Demonstrates Antitumor Activity in P-gp-Overexpressing Cancer Models. [PDF]

Mol Cancer Ther
Xie Y, Hou R, Albadari N, Chen H, Miller DJ, Quadrozzi Gruntz J, Oldham ML, Kamal MS, Jiang J, Wu Z, Miller DD, Li W.   +11 more
europepmc   +1 more source